Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Tattelecom reported for 9 months of 2024 by RAS

11/14/24 TTLK

CarMoney reported for 9 months of 2024 by IFRS

11/14/24 CARM

Softline reported for 9 months of 2024 by IFRS

11/14/24 SOFL

Board of Directors of Lenzoloto recommended dividends

11/13/24 LNZL

Slavneft-Megionneftegaz reported for 9 months of 2024 by RAS

11/13/24 MFGS

Rosoboronexport signs first contracts for Su-57 deliveries

11/13/24 UNAC

Number of sites with VK video player doubled

11/13/24 VKCO

Cherkizovo buys Duck Farms

11/13/24 GCHE

En+ Group completed modernization of a hydropower unit at Bratskaya HPP

11/13/24 ENPG

Rusagro consolidated 100% of GK Agro-Belogorye

11/13/24 AGRO